Inventor · disambiguated record
Gary J. Nabel
Also filed as: NABEL GARY · NABEL GARY J · NABEL GARY JAN
109 granted patents·58 pending applications·10,985 citations·filing 1982–2025
99Inventor score
Top patents by PatentIndex Score
167 records- 0199US7232566B2Methods for treating HIV infected subjectsGENETICS INST LLC·Filed 2005·Granted Jun 19, 2007·814 cites·64 claims
- 0299US7175843B2Methods for selectively stimulating proliferation of T cellsUS NAVY·Filed 2006·Granted Feb 13, 2007·821 cites·65 claims
- 0399US7144575B2Methods for selectively stimulating proliferation of T cellsUS NAVY·Filed 2003·Granted Dec 5, 2006·799 cites·24 claims
- 0499US6905681B1Methods for selectively stimulating proliferation of T cellsINST GENETICS LLC·Filed 1999·Granted Jun 14, 2005·913 cites·18 claims
- 0599US6905680B2Methods of treating HIV infected subjectsUS NAVY·Filed 1996·Granted Jun 14, 2005·879 cites·14 claims
- 0699US6887466B2Methods for selectively stimulating proliferation of T cellsUS NAVY·Filed 1999·Granted May 3, 2005·914 cites·19 claims
- 0799US6534055B1Methods for selectively stimulating proliferation of T cellsGENETICS INST·Filed 1995·Granted Mar 18, 2003·1k cites·29 claims
- 0899US6352694B1Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cellsGENETICS INST·Filed 1995·Granted Mar 5, 2002·1.2k cites·32 claims
- 0999US5858358AMethods for selectively stimulating proliferation of T cellsUS NAVY·Filed 1994·Granted Jan 12, 1999·885 cites·33 claims
- 1099US5328470ATreatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits thereforUNIV MICHIGAN·Filed 1991·Granted Jul 12, 1994·1.2k cites·10 claims
- 1197US8454972B2Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogenNABEL GARY J·Filed 2011·Granted Jun 4, 2013·212 cites·10 claims
- 1297US7479269B2Methods for selectively enriching TH1 and TH2 cellsGENETICS INST LLC·Filed 2006·Granted Jan 20, 2009·32 cites·12 claims
- 1397US5698531ATreatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits thereforUNIV MICHIGAN·Filed 1995·Granted Dec 16, 1997·162 cites·15 claims
- 1496US11192960B2Trispecific and/or trivalent binding proteinsSANOFI SA·Filed 2020·Granted Dec 7, 2021·6 cites·30 claims
- 1596US10882922B2Trispecific and/or trivalent binding proteinsSANOFI SA·Filed 2017·Granted Jan 5, 2021·20 cites·47 claims
- 1696US7094598B2Development of a preventive vaccine for filovirus infection in primatesUS HEALTH·Filed 2004·Granted Aug 22, 2006·43 cites·7 claims
- 1795US11779651B2Bivalent, bispecific binding proteins for prevention or treatment of HIV infectionSANOFI SA·Filed 2021·Granted Oct 10, 2023·2 cites·3 claims
- 1895US11718647B2Virus-like particles and methods of useUS HEALTH·Filed 2021·Granted Aug 8, 2023·2 cites·14 claims
- 1995US11530268B2Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of use for treating viral infectionSANOFI SA·Filed 2019·Granted Dec 20, 2022·15 cites·34 claims
- 2095US9487563B2Virus-like particles and methods of useNABEL GARY J·Filed 2012·Granted Nov 8, 2016·18 cites·19 claims
- 2195US9353353B2Virus-like particles (VLPs) prepared from chikungunya virus structural proteinsNABEL GARY J·Filed 2009·Granted May 31, 2016·29 cites·9 claims
- 2294US11613576B2Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2020·Granted Mar 28, 2023·3 cites·29 claims
- 2394US11186649B2Anti-CD38 antibodies and methods of useSANOFI SA·Filed 2018·Granted Nov 30, 2021·10 cites·41 claims
- 2494US10035844B2Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope proteinUS HEALTH·Filed 2017·Granted Jul 31, 2018·6 cites·32 claims
- 2594US8106026B2Development of a preventive vaccine for filovirus infection in primatesNABEL GARY J·Filed 2009·Granted Jan 31, 2012·11 cites·9 claims
- 2694US5324818AProteins useful in the regulation of κB-containing genesUNIV MICHIGAN·Filed 1991·Granted Jun 28, 1994·111 cites·2 claims
- 2793US11129905B2Bivalent, bispecific binding proteins for prevention or treatment of HIV infectionSANOFI SA·Filed 2019·Granted Sep 28, 2021·6 cites·3 claims
- 2893US9441019B2Influenza hemagglutinin protein-based vaccinesUS HEALTH·Filed 2012·Granted Sep 13, 2016·30 cites·21 claims
- 2993US8637036B2Neutralizing antibodies to HIV-1 and their useMASCOLA JOHN R·Filed 2012·Granted Jan 28, 2014·22 cites·23 claims
- 3093US8323961B2HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIVNABEL GARY J·Filed 2011·Granted Dec 4, 2012·13 cites·2 claims
- 3193US5863904AMethods for treating cancers and restenosis with P21UNIV MICHIGAN·Filed 1995·Granted Jan 26, 1999·93 cites·8 claims
- 3292US11098084B2Virus-like particles and methods of useTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2018·Granted Aug 24, 2021·3 cites·10 claims
- 3392US7947822B2HIV vaccines based on Env of multiple clades of HIVUS HEALTH·Filed 2010·Granted May 24, 2011·17 cites·3 claims
- 3491US10138277B2Virus-like particles and methods of useUS HEALTH·Filed 2016·Granted Nov 27, 2018·3 cites·9 claims
- 3591US9695230B2Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope proteinUS HEALTH·Filed 2012·Granted Jul 4, 2017·9 cites·41 claims
- 3691US5910488APlasmids suitable for gene therapyVICAL INC·Filed 1994·Granted Jun 8, 1999·145 cites·22 claims
- 3791US5707969ATreatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits thereforUNIV MICHIGAN·Filed 1995·Granted Jan 13, 1998·73 cites·13 claims
- 3891US2025326801A1Virus-like particles and methods of useTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2024·Application pending·0 cites
- 3990US10137190B2Nucleic acid molecules encoding ferritin-hemagglutinin fusion proteinsUS HEALTH·Filed 2016·Granted Nov 27, 2018·10 cites·17 claims
- 4090US6218372B1Methods for treating restenosis with p21UNIV MICHIGAN·Filed 1999·Granted Apr 17, 2001·70 cites·15 claims
- 4189US12281336B2Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteinsUS HEALTH·Filed 2024·Granted Apr 22, 2025·0 cites·5 claims
- 4288US10369208B2Methods for the induction of immune responses in a subject compromising administering virus-like particles (VLPS) prepared from Chikungunya virus structural proteinsUS HEALTH·Filed 2016·Granted Aug 6, 2019·5 cites·6 claims
- 4388US9526777B2Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoproteinSULLIVAN NANCY J·Filed 2011·Granted Dec 27, 2016·7 cites·5 claims
- 4488US8124592B2Development of a preventive vaccine for filovirus infection in primatesNABEL GARY J·Filed 2009·Granted Feb 28, 2012·3 cites·9 claims
- 4588US8106027B2Development of a preventive vaccine for filovirus infection in primatesNABEL GARY J·Filed 2009·Granted Jan 31, 2012·3 cites·9 claims
- 4688US8101739B2Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vectorSULLIVAN NANCY·Filed 2005·Granted Jan 24, 2012·10 cites·8 claims
- 4787US12168675B2Virus-like particles and methods of useUS HEALTH·Filed 2023·Granted Dec 17, 2024·0 cites·12 claims
- 4887US10744199B2Epstein-Barr virus vaccinesTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2014·Granted Aug 18, 2020·4 cites·9 claims
- 4987US9012618B2Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structuresSULLIVAN NANCY·Filed 2012·Granted Apr 21, 2015·5 cites·8 claims
- 5087US6057300AMethods for treating cancers and restenosis with p21UNIV MICHIGAN·Filed 1998·Granted May 2, 2000·56 cites·3 claims
Showing the top 50 of 167 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gary J. Nabel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →